Moderna, Inc.
MRNA
$53.57
$1.863.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -33.61% | 753.51% | |||
| Total Other Revenue | -25.58% | 53.57% | |||
| Total Revenue | -33.27% | 615.49% | |||
| Cost of Revenue | 21.73% | 23.08% | |||
| Gross Profit | -6,962.50% | 101.18% | |||
| SG&A Expenses | 14.93% | 16.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.30% | 21.64% | |||
| Operating Income | -229.62% | 71.33% | |||
| Income Before Tax | -327.27% | 77.14% | |||
| Income Tax Expenses | 107.69% | 85.71% | |||
| Earnings from Continuing Operations | -313.00% | 75.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -313.00% | 75.76% | |||
| EBIT | -229.62% | 71.33% | |||
| EBITDA | -279.81% | 75.53% | |||
| EPS Basic | -310.90% | 75.88% | |||
| Normalized Basic EPS | -315.13% | 76.77% | |||
| EPS Diluted | -310.90% | 75.88% | |||
| Normalized Diluted EPS | -315.13% | 76.77% | |||
| Average Basic Shares Outstanding | 0.51% | 0.52% | |||
| Average Diluted Shares Outstanding | 0.51% | 0.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||